Hepatocellular Carcinoma in an HIV Patient "Cured" of Hepatitis C Virus.
作者信息
Swaminath Arun
机构信息
University of California, San Diego.
出版信息
Gastroenterol Hepatol (N Y). 2006 Aug;2(8):599-602.
Abstract
摘要
相似文献
1
Hepatocellular Carcinoma in an HIV Patient "Cured" of Hepatitis C Virus.
Gastroenterol Hepatol (N Y). 2006 Aug;2(8):599-602.
2
Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?
Liver Int. 2018 Dec;38(12):2108-2116. doi: 10.1111/liv.13918. Epub 2018 Jul 21.
3
Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
World J Gastroenterol. 2018 Feb 7;24(5):613-622. doi: 10.3748/wjg.v24.i5.613.
4
Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients.
Curr Opin Oncol. 2002 Sep;14(5):538-42. doi: 10.1097/00001622-200209000-00011.
5
A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma Progression.
J Infect Dis. 2018 Mar 5;217(6):857-860. doi: 10.1093/infdis/jix659.
6
Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.
Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):570-2. doi: 10.1016/s0035-9203(97)90029-8.
7
[Clinical and etiologic features of hepatocarcinoma in Sicily].
Ann Ital Med Int. 1999 Oct-Dec;14(4):233-8.
8
Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria.
Arch Virol Suppl. 1992;4:76-80. doi: 10.1007/978-3-7091-5633-9_16.
9
A lack of direct role of hepatitis B virus in the activation of ras and c-myc oncogenes in human hepatocellular carcinogenesis.
Hepatology. 1988 Sep-Oct;8(5):1116-20. doi: 10.1002/hep.1840080524.
10
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Hepatogastroenterology. 2003 Sep-Oct;50(53):1564-8.
本文引用的文献
1
Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
Clin Gastroenterol Hepatol. 2006 Jan;4(1):29-35. doi: 10.1016/s1542-3565(05)00864-5.
2
The surveillance and diagnosis of hepatocellular carcinoma.
Eur J Gastroenterol Hepatol. 2005 May;17(5):491-6. doi: 10.1097/00042737-200505000-00004.
3
Hepatocellular carcinoma.
Curr Opin Gastroenterol. 2005 May;21(3):308-12. doi: 10.1097/01.mog.0000159817.55661.ca.
4
Screening for hepatocellular carcinoma.
Dig Liver Dis. 2005 Apr;37(4):260-8. doi: 10.1016/j.dld.2004.11.005. Epub 2005 Jan 26.
5
Treatment of hepatocellular carcinoma.
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):129-45. doi: 10.1016/j.bpg.2004.11.008.
6
Serological markers of liver cancer.
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):91-9. doi: 10.1016/j.bpg.2004.10.003.
7
Liver transplantation for hepatocellular carcinoma in cirrhosis: is clinical tumor classification before transplantation realistic?
Transplantation. 2005 Feb 27;79(4):483-7. doi: 10.1097/01.tp.0000152801.82734.74.
8
The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
Am J Gastroenterol. 2005 Jan;100(1):56-63. doi: 10.1111/j.1572-0241.2005.40670.x.
9
Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease.
J Infect Dis. 2005 Jan 1;191(1):4-10. doi: 10.1086/426513. Epub 2004 Dec 2.
10
Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum.
Lancet Oncol. 2004 Jul;5(7):409-18. doi: 10.1016/S1470-2045(04)01508-6.
Zotero 插件